![Sherwin Sattarzadeh](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Sherwin Sattarzadeh
Inga fler pågående positioner
Förmögenhet: 5 M $ per 2026-06-30
Profil
Mr. Sherwin Sattarzadeh was previously employed as a Chief Executive & Operating Officer by Damora Therapeutics, Inc., a Chief Business Officer by Blueprint Medicines Corp., and a Director-Regulatory Affairs by Genzyme Corp.
He received his undergraduate degree from the University of British Columbia and an MBA from Boston University.
Kända innehav i offentliga företag
| Företag | Datum | Antal aktier | Värdering | Värderingsdatum |
|---|---|---|---|---|
| 2026-01-05 | 190 376 ( 0,31 % ) | 5 M $ | 2026-06-30 |
Tidigare kända positioner av Sherwin Sattarzadeh
| Företag | Position | Slut |
|---|---|---|
| DAMORA THERAPEUTICS, INC. | Verkställande Direktör | 2026-03-30 |
| BLUEPRINT MEDICINES CORPORATION | Personalchef | - |
Genzyme Corp.
 Genzyme Corp. Pharmaceuticals: MajorHealth Technology Develops and manufactures therapies for rare diseases, multiple sclerosis, immunology & oncology | Generell Rådgivare | 2015-07-01 |
Sherwin Sattarzadehs utbildningar
Erfarenheter
Innehade positioner
Aktiva
Inaktiva
Börsnoterade företag
Privata företag
Relationer
70
Första gradens relationer
5
Företag kopplade till första graden
Man
Kvinna
Styrelseledamöter
Chefer
Kopplade företag
| Privata företag | 5 |
|---|---|
Genzyme Corp.
Genzyme Corp. Pharmaceuticals: MajorHealth Technology Develops and manufactures therapies for rare diseases, multiple sclerosis, immunology & oncology | Health Technology |
Boston University
 Boston University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of British Columbia
 University of British Columbia Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Blueprint Medicines Corp.
 Blueprint Medicines Corp. BiotechnologyHealth Technology Develops cancer therapies that harness the growing understanding of the molecular blueprint of cancer | Health Technology |
Galecto, Inc.
 Galecto, Inc. Pharmaceuticals: MajorHealth Technology Develops drugs for treatment of severe diseases | Health Technology |
